|Articles|January 1, 2012
- Pharmaceutical Executive-01-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2012
Industry Forecast 2012 : Bridging the Divide
Advertisement
Articles in this issue
almost 14 years ago
Hungary Report: Redefining Sustainabilityalmost 14 years ago
Emerging Markets: Bridging the Cancer Dividealmost 14 years ago
Financing R&D Through a Range of Consumer Productsalmost 14 years ago
New Year, New Issuesalmost 14 years ago
Innovation: Why is Pharma Scared to Death?almost 14 years ago
Top Medical Innovations 2012almost 14 years ago
Essential Questions for Essential Benefitsalmost 14 years ago
Copay Cards and Coupons: Letting the Facts Get in the Wayalmost 14 years ago
Pharma 2012: Hard Times Before the Harvestalmost 14 years ago
Here's to a Happier New Year?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
5
